Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: October 25th 2024 | Updated: October 29th 2024
Nab-Sirolimus and Its Role in PEComa Treatment
Published: October 24th 2024 | Updated: October 29th 2024
The Present and Future of Endocrine Therapy in Breast Cancer
Published: October 25th 2024 | Updated: October 29th 2024
Emerging Endocrine Therapies in Breast Cancer Treatment
Published: October 25th 2024 | Updated: October 29th 2024
Upcoming Endocrine Therapy Developments Excite in Breast Cancer
Published: October 28th 2024 | Updated: October 29th 2024
Comparing Emerging Classes of Endocrine Therapies in Breast Cancer